Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
J.POD® 2 EU biomanufacturing will play a key role in addressing the need for therapeutic antibodies, including those related to infectious diseases such as COVID-19